Aptevo Therapeutics Inc. (APVO) has a market capitalization of $11.18M and trades at $5.39. The 52-week range is 3.84-583.2.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.1, Earnings Per Share (EPS) of $-87.27.
The stock has a beta of 1.43, operates in the Healthcare sector.
